Predictive value of three comorbidity indices for survival endpoints in oral squamous cell carcinoma
Authors:
- 18 June 2025
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 167, 107443
Abstract
No abstract availableKeywords
Funding Information
- Beijing Natural Science Foundation (7252058)
- Beijing Nova Program (20230484404)
- Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park (Z221100007422046)
- Beijing Hospitals Authority Clinical Medicine Development of Specific Funding Support (YGLX202338)
This publication has 40 references indexed in Scilit:
- Adjuvant (chemo)radiotherapy for patients with head and neck cancer: can comorbidity risk scores predict outcome?Strahlentherapie und Onkologie, 2024
- The small extracellular vesicle‐mediated intercellular transformation of CXCR1Low to CXCR1High tumour cells promotes the progression of head and neck squamous cell carcinomaJournal of Extracellular Vesicles, 2024
- Oropharyngeal dysphagia and cachexia: Intertwined in head and neck cancerHead & Neck, 2022
- Development and validation of a nomogram for the prediction of lymph node metastasis within 2‐year postoperatively in cT1‐T2N0 oral squamous cell carcinomaHead & Neck, 2022
- Value of six comorbidity scales for predicting survival of patients with primary surgery for oral squamous cell carcinomaHead & Neck, 2022
- The Utility of Comorbidity Indices in Assessing Head and Neck Surgery Outcomes: A Systematic ReviewThe Laryngoscope, 2021
- Influence of comorbidity on therapeutic decision making and impact on outcomes in patients with head and neck squamous cell cancers: Results from a prospective cohort studyHead & Neck, 2018
- Age‐adjusted comorbidity and survival in locally advanced laryngeal cancerHead & Neck, 2018
- Impact of comorbidities by ACE‐27 in the revised‐IPSS for patients with myelodysplastic syndromesAmerican Journal of Hematology, 2014
- Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancerCancer, 2008